These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7781662)

  • 1. Hormonal and renal responses to neutral endopeptidase inhibition in normal humans on a low and on a high sodium intake.
    Sagnella GA; Markandu ND; Buckley MG; Miller MA; Blackwood A; Singer DR; MacGregor GA
    Eur J Clin Invest; 1995 Mar; 25(3):165-70. PubMed ID: 7781662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary sodium and inhibition of neutral endopeptidase 24.11 in essential hypertension.
    Singer DR; Markandu ND; Buckley MG; Miller MA; Sagnella GA; MacGregor GA
    Hypertension; 1991 Dec; 18(6):798-804. PubMed ID: 1835959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of renal neutral endopeptidase inhibition on sodium excretion, renal hemodynamics and neurohormonal activation in patients with congestive heart failure.
    Kimmelstiel CD; Perrone R; Kilcoyne L; Souhrada J; Udelson J; Smith J; de Bold A; Griffith J; Konstam MA
    Cardiology; 1996; 87(1):46-53. PubMed ID: 8631044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candoxatril, an orally active neutral endopeptidase inhibitor, raises plasma atrial natriuretic factor and is natriuretic in essential hypertension.
    O'Connell JE; Jardine AG; Davidson G; Connell JM
    J Hypertens; 1992 Mar; 10(3):271-7. PubMed ID: 1315825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormonal responses to gradual changes in dietary sodium intake in humans.
    Sagnella GA; Markandu ND; Buckley MG; Miller MA; Singer DR; MacGregor GA
    Am J Physiol; 1989 Jun; 256(6 Pt 2):R1171-5. PubMed ID: 2525347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms underlying the augmented responses of deoxycorticosterone acetate-salt hypertensive rats to neutral endopeptidase inhibitors.
    Hirata Y; Suzuki Y; Suzuki E; Hayakawa H; Kimura K; Goto A; Omata M; Minamino N; Kangawa K; Matsuo H
    J Hypertens; 1994 Apr; 12(4):367-74. PubMed ID: 8064160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is atrial natriuretic peptide-guanosine 3',5' cyclic monophosphate coupling a determinant of urinary sodium excretion in essential hypertension?
    Sagnella GA; Singer DR; Markandu ND; Buckley MG; MacGregor GA
    J Hypertens; 1992 Apr; 10(4):349-54. PubMed ID: 1316400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of endopeptidase inhibition (candoxatril) in congestive heart failure.
    Elsner D; Müntze A; Kromer EP; Riegger GA
    Am J Cardiol; 1992 Aug; 70(4):494-8. PubMed ID: 1386491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal and hormonal effects of chronic inhibition of neutral endopeptidase (EC 3.4.24.11) in normal man.
    O'Connell JE; Jardine AG; Davies DL; McQueen J; Connell JM
    Clin Sci (Lond); 1993 Jul; 85(1):19-26. PubMed ID: 8149689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma atrial natriuretic peptide, aldosterone, and plasma renin activity responses to gradual changes in dietary sodium intake.
    Sagnella GA; Markandu ND; Buckley MG; Miller MA; Singer DR; MacGregor GA
    Am J Hypertens; 1990 Nov; 3(11):863-5. PubMed ID: 2148092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of atrial natriuretic peptide in urine from rats treated with a neutral endopeptidase inhibitor.
    Suzuki E; Hirata Y; Matsuoka H; Sugimoto T; Hayakawa H; Sugimoto T; Kangawa K; Minamino N; Matsuo H
    Biochem Biophys Res Commun; 1992 Feb; 182(3):1270-6. PubMed ID: 1531753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of endopeptidase EC 24.11 in humans. Renal and endocrine effects.
    Richards M; Espiner E; Frampton C; Ikram H; Yandle T; Sopwith M; Cussans N
    Hypertension; 1990 Sep; 16(3):269-76. PubMed ID: 2144260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of inhibition of endopeptidase 24.11 on responses to angiotensin II in human volunteers.
    Richards AM; Wittert GA; Espiner EA; Yandle TG; Ikram H; Frampton C
    Circ Res; 1992 Dec; 71(6):1501-7. PubMed ID: 1423942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candoxatril, a neutral endopeptidase inhibitor: efficacy and tolerability in essential hypertension.
    Bevan EG; Connell JM; Doyle J; Carmichael HA; Davies DL; Lorimer AR; McInnes GT
    J Hypertens; 1992 Jul; 10(7):607-13. PubMed ID: 1321186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic inhibition of endopeptidase 24.11 in essential hypertension: evidence for enhanced atrial natriuretic peptide and angiotensin II.
    Richards AM; Wittert GA; Crozier IG; Espiner EA; Yandle TG; Ikram H; Frampton C
    J Hypertens; 1993 Apr; 11(4):407-16. PubMed ID: 8390508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of urinary atrial natriuretic peptide interferes with macula densa function.
    Haloui M; Messika-Zeitoun D; Louedec L; Philippe M; Michel JB
    Cardiovasc Res; 2001 Aug; 51(3):542-52. PubMed ID: 11476744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of the natriuretic effects of neutral endopeptidase inhibition in Dahl salt-sensitive and salt-resistant rats.
    Hirata Y; Suzuki E; Hayakawa H; Matsuoka H; Sugimoto T; Kangawa K; Matsuo H
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):283-90. PubMed ID: 7511759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a dual inhibitor of angiotensin converting enzyme and neutral endopeptidase, MDL 100,240, on endocrine and renal functions in healthy volunteers.
    Rousso P; Buclin T; Nussberger J; Décosterd LA; La Roche SD; Brunner-Ferber F; Brunner HR; Biollaz J
    J Hypertens; 1999 Mar; 17(3):427-37. PubMed ID: 10100082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of candoxatril and atrial natriuretic factor in healthy men. Effects on hemodynamics, sympathetic activity, heart rate variability, and endothelin.
    Ando S; Rahman MA; Butler GC; Senn BL; Floras JS
    Hypertension; 1995 Dec; 26(6 Pt 2):1160-6. PubMed ID: 7498988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of low and high sodium diets on plasma atrial natriuretic factor, the renin-aldosterone system and blood pressure in subjects with essential hypertension.
    McKnight JA; Roberts G; Sheridan B; Atkinson AB
    Clin Endocrinol (Oxf); 1994 Jan; 40(1):73-7. PubMed ID: 8306484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.